Abstract:Background: Depressive symptom may associate with daily recommended dose of Isotretinoin for nodulocystic acne. Does reducing the dose will reduce the incidence of depressive symptoms is still not clearly understood. Study objective: To compare the types and frequency of depressive symptoms among patients with nodulocystic acne receiving three different low doses of isotretinoin (10mg daily, 20mg every other day, and 20mg daily). Study design: Open randomized clinical trial. Study setting: Dermatology clinic a… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.